Lv3
350 积分 2022-12-06 加入
Allogeneic double-negative CAR-T cells inhibit tumor growth without off-tumor toxicities
6天前
已完结
Circulating CXCR5+CD4+ T cells assist in the survival and growth of primary diffuse large B cell lymphoma cells through interleukin 10 pathway
21天前
已完结
T follicular helper cells in cancer
21天前
已完结
T Follicular Helper Cell Heterogeneity
2个月前
已完结
Interleukin 21 – its potential role in the therapy of B-cell lymphomas
3个月前
已完结
Synthetic manipulation of the cancer-immunity cycle: CAR-T cell therapy
4个月前
已完结
Optimizing the manufacturing and antitumour response of CAR T therapy
4个月前
已完结
Emerging Biomarkers for Monitoring Chimeric Antigen Receptor T-Cell Therapy
4个月前
已完结
Comprehensive peripheral blood immunoprofiling reveals five immunotypes with immunotherapy response characteristics in patients with cancer
4个月前
已完结
Brentuximab vedotin with dacarbazine or nivolumab as frontline cHL therapy for older patients ineligible for chemotherapy
4个月前
已完结
皖公网安备34019202002308
